SUZUKEN CO.,LTD.
9987・Prime Market・Wholesale Trade
SUZUKEN CO.,LTD.9987
SUZUKEN CO.,LTD.9987
Reference Indicators
Market Cap
3,735¥100M
P/E (Forecast)
11.4x
P/B
0.8x
Dividend Yield (Forecast)
1.93%
ROE
9.3%
EV/EBITDA
5.3x
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 2,232,774 | 2,314,828 | 2,386,493 | 2,399,952 | 2,486,647 |
Cost of Sales | 2,071,780 | 2,135,133 | 2,201,244 | 2,207,720 | 2,294,122 |
Gross Profit | 160,994 | 179,694 | 185,249 | 192,231 | 192,524 |
SG&A Expenses | 147,216 | 147,089 | 150,373 | 155,106 | 156,149 |
Operating Income | 13,777 | 32,605 | 34,875 | 37,125 | 36,374 |
Non-operating Income | 10,185 | 4,372 | 3,963 | 2,868 | 3,828 |
Non-operating Expenses | 545 | 601 | 488 | 1,163 | 458 |
Ordinary Income | 23,418 | 36,376 | 38,351 | 38,830 | 39,744 |
Extraordinary Income | 8,192 | 209 | 8,377 | 14,202 | 17,768 |
Extraordinary Losses | 9,125 | 5,991 | 3,935 | 2,744 | 3,218 |
Pre-tax Income | 22,484 | 30,594 | 42,793 | 50,287 | 54,293 |
Income Taxes | 8,012 | 10,275 | 13,793 | 15,783 | 16,150 |
Net Income | 14,393 | 20,345 | 29,016 | 34,496 | 38,136 |
EBITDA | 23,796 | 41,449 | 43,619 | 49,188 | 48,725 |
Gross Margin | 7.2% | 7.8% | 7.8% | 8.0% | 7.7% |
Operating Margin | 0.6% | 1.4% | 1.5% | 1.5% | 1.5% |
ROA | 1.3% | 1.8% | 2.4% | 3.1% | 3.3% |
ROE | 3.4% | 4.9% | 7.0% | 8.4% | 9.3% |
Segment Performance
Unit: ¥M
2026
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| 医薬品卸売事業 | 2,349,386 | 31,467 | 1.3% |
| ヘルスケア製品開発事業 | 11,933 | 830 | 7.0% |
| 地域医療介護支援事業 | 93,922 | 1,549 | 1.6% |
| スペシャリティ医薬品流通受託事業 | 6,775 | 1,155 | 17.0% |
| 医療関連サービス等事業 | 24,629 | 1,276 | 5.2% |